← Back to Search

Other

Diet 1 for Crohn's Disease

N/A
Waitlist Available
Led By Timothy L Zisman, MD, MPH
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Crohn's disease made by a primary gastroenterologist based upon history, physical exam, laboratory/radiological studies, and endoscopy with biopsy.
Consentable adults of age 18 or older.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

Recent data suggest that diet in inflammatory bowel disease (IBD) may lead to both symptom control and disease remission. Historically certain diets have been recommended for patients with Crohn's disease during exacerbations despite lack of data supporting efficacy. The investigators propose to evaluate two such diets by randomizing 32 subjects with mildly to moderately active Crohn's disease to one of two diets that differ in the amount and type of carbohydrates and fiber. Subjects will remain on the diet for 8 weeks and will be evaluated for changes from baseline in inflammatory biomarkers, symptomatic disease activity, and the microbiome.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fecal Calprotectin Remission
Secondary outcome measures
Clinical Response
Fecal Calprotectin Response
Future Use
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Diet 2Experimental Treatment1 Intervention
Administered for 8 weeks.
Group II: Diet 1Experimental Treatment1 Intervention
Administered for 8 weeks.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,728 Previous Clinical Trials
1,840,897 Total Patients Enrolled
Timothy L Zisman, MD, MPHPrincipal InvestigatorUniversity of Washington

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Mar 2025